HendersonMK, Simeon-DubachD, AlbertM. Finding the path to biobank sustainability through sound business planning. Biopreserv Biobank, 2015; 13:385–386.
2.
HendersonMK, Simeon-DubachD, ZaayengaA. When bad things happen: Lessons learned from effective and not so effective disaster and recovery planning for biobanks. Biopreserv Biobank, 2013; 11:193.
3.
Simeon-DubachD, HendersonMK. Sustainability in biobanking. Biopreserv Biobank, 2014; 12:287–291.
4.
WatsonPH, NussbeckSY, CarterC, et al.A framework for biobank sustainability. Biopreserv Biobank, 2014; 12:60–68.
5.
AlbertM, BartlettJ, JohnstonRN, SchacterB, WatsonP. Biobank bootstrapping: Is biobank sustainability possible through cost recovery?. Biopreserv Biobank, 2014; 12:374–380.
6.
SargsyanK, MacheinerT, StoryP, et al.Sustainability in biobanking: Model of biobank graz. Biopreserv Biobank, 2015; 13:410–420.
7.
BromleyRL. Financial stability in biobanking: Unique challenges for disease-focused foundations and patient advocacy organizations. Biopreserv Biobank, 2014; 12:294–299.
8.
BarnesRO, SchacterB, KodeeswaranS, WatsonPH. Funding sources for Canadian biorepositories: The role of user fees and strategies to help fill the gap. Biopreserv Biobank, 2014; 12:300–305.
9.
WilsonGD, D'AngeloK, PruetzBL, GeddesTJ, LarsonDM, AkervallJ. The challenge of sustaining a hospital-based biobank and core molecular laboratory: The Beaumont experience. Biopreserv Biobank, 2014; 12:306–311.
10.
Matharoo-BallB, ThomsonBJ. Nottingham Health Science Biobank: A sustainable bioresource. Biopreserv Biobank, 2014; 12:312–316.
11.
SeilerCY, EschbacherJ, BowserR, LaBaerJ. Sustainability in a hospital-based biobank and university-based DNA biorepository: Strategic roadmaps. Biopreserv Biobank, 2015; 13:401–409.
WilesKR, WashingtonMK. Implementation of an error-reporting module within a biorepository IT application to enhance operations. Biopreserv Biobank, 2014; 12:365–373.
14.
Parry-JonesA. Assessing the financial, operational, and social sustainability of a biobank: The Wales Cancer Bank case study. Biopreserv Biobank, 2014; 12:381–388.
15.
CarpenterJE, ClarkeCL. Biobanking sustainability—Experiences of the Australian Breast Cancer Tissue Bank (ABCTB). Biopreserv Biobank, 2014; 12:395–401.
16.
WarthR, PerrenA. Construction of a business model to assure financial sustainability of biobanks. Biopreserv Biobank, 2014; 12:389–394.
17.
Simeon-DubachD, WatsonP. Biobanking 3.0: Evidence based and customer focused biobanking. Clin Biochem, 2014; 47:300–308.
18.
MooreHM, KellyAB, JewellSD, et al.Biospecimen reporting for improved study quality (BRISQ). Biopreserv Biobank, 2011; 9:57–70.
19.
BensonEE, BetsouF, AmaralR, SantosLM, HardingK. Standard PREanalytical codes: A new paradigm for environmental biobanking sectors explored in algal culture collections. Biopreserv Biobank, 2011; 9:399–410.
20.
CadiganRJ, JuengstE, DavisA, HendersonG. Underutilization of specimens in biobanks: An ethical as well as a practical concern?. Genet Med, 2014; 16:738–740.
